Get the Stockscreener App
1.52
3.40%
0.05
Bionano Genomics Inc stock is traded at $1.52, with a volume of 829.45K.
It is up +3.40% in the last 24 hours and down -27.27% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.47
Open:
$1.55
24h Volume:
829.45K
Relative Volume:
1.20
Market Cap:
$14.83M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.0855
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-6.75%
1M Performance:
-27.27%
6M Performance:
-59.36%
1Y Performance:
-90.10%
1-Day Range:
$1.50
$1.76
1-Week Range:
$1.465
$1.76
52-Week Range:
$1.465
$22.80
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.52 | 14.23M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Is Bionano Genomics Inc. stock entering bullish territoryEarnings Growth Summary & Entry Point Strategy Guides - newser.com
How Bionano Genomics Inc. stock benefits from tech adoptionQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript - Insider Monkey
Measuring Bionano Genomics Inc.’s beta against major indicesJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... - Yahoo Finance
Will Bionano Genomics Inc. stock maintain growth story2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
Bionano Genomics Reports Strong Q3 2025 Results - TipRanks
Bionano (BNGO) Q3 2025 Earnings Call Transcript - The Globe and Mail
Transcript : Bionano Genomics, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Earnings call transcript: Bionano Genomics Q3 2025 sees 21% revenue growth - Investing.com Nigeria
Bionano jumps 6% on Q3 revenue beat, 2025 guidance range - MSN
Bionano Genomics Q3 2025 slides: 21% revenue growth amid cost structure improvements - Investing.com
Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN
Bionano Genomics Cuts Costs And Rises Above Expectations - Finimize
Genome mapping firm Bionano Q3 rev beats estimates on higher utilization by routine users - MarketScreener
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q3 2025 Financial Results - TradingView
Building trade automation scripts for Bionano Genomics Inc.July 2025 Setups & Technical Pattern Based Buy Signals - newser.com
How to build a custom watchlist for Bionano Genomics Inc.July 2025 Opening Moves & Daily Momentum Trading Reports - newser.com
Full technical analysis of Bionano Genomics Inc. stock2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What moving averages say about Bionano Genomics Inc.July 2025 Market Mood & Risk Controlled Daily Trade Plans - newser.com
Bionano Genomics Inc. stock chart pattern explained2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 R - GuruFocus
Combining price and volume data for Bionano Genomics Inc.CEO Change & AI Enhanced Market Trend Forecasts - newser.com
Using flow based indicators on Bionano Genomics Inc.July 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Applying chart zones and confluence areas to Bionano Genomics Inc.July 2025 Spike Watch & High Yield Stock Recommendations - newser.com
Will Bionano Genomics Inc. stock beat EPS estimatesTrade Entry Report & Weekly Setup with ROI Potential - newser.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):